Nosenzo John 4
4 · Bioventus Inc. · Filed Apr 21, 2023
Insider Transaction Report
Form 4
Nosenzo John
Chief Commercial Officer
Transactions
- Sale
Class A Common Stock
2022-04-01$14.07/sh−40$563→ 87,250 total - Sale
Class A Common Stock
2022-07-01$6.73/sh−95$639→ 87,155 total - Sale
Class A Common Stock
2022-10-03$7.00/sh−7$49→ 87,148 total
Footnotes (2)
- [F1]Reflects shares sold to cover taxes in connection with shares purchased under the Company's 2021 Employee Stock Purchase Plan.
- [F2]Includes an aggregate of 3,398 shares of Class A common stock purchased under the Company's 2021 Employee Stock Purchase Plan. This number has also been adjusted to account for a scrivener's error in a prior filing which attributed an acquisition of 40 shares under the Company's 2021 Employee Stock Purchase Plan.